Status:
TERMINATED
TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTA
Lead Sponsor:
Instituto de Investigación Marqués de Valdecilla
Conditions:
Arterial Hypertension
Sodium Urine
Eligibility:
All Genders
40+ years
Brief Summary
Arterial hypertension is an independent vascular risk factor and a frequent reason for consultation in Primary Care. It generates high cardiovascular morbidity and mortality (stroke, heart disease, ki...
Detailed Description
In the present work, with a prospective cohort observational study design, it intends to assess the effectiveness of the use of an educational program based on the follow up of a hyposodium diet and a...
Eligibility Criteria
Inclusion
- Patients over 40 years old.
- Patients diagnosed with HTA (according to criteria ESC/ESH 2018) in a PA consultation or through MAP at the health center.
- In treatment with single, double or triple antihypertensive therapy.
- Patients with ST figures ≥140.
- Patients with TD numbers ≥90.
- Patients with stable antihypertensive treatment or without modifications in the treatment at least in the last month.
- Patients who commit to follow up the study.
- Patients who have given written informed consent.
Exclusion
- Patients with decompensated heart failure
- Severe renal failure.
- Decompensated liver disease.
- Taking non-insulin antidiabetic
- Hypertension of pharmacological origin and other causes.
Key Trial Info
Start Date :
September 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2022
Estimated Enrollment :
2 Patients enrolled
Trial Details
Trial ID
NCT04677322
Start Date
September 1 2020
End Date
September 1 2022
Last Update
March 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centro de salud Astillero
Santander, Cantabria, Spain, 39610